Literature DB >> 9813259

Systemic gabapentin and S(+)-3-isobutyl-gamma-aminobutyric acid block secondary hyperalgesia.

D L Jones1, L S Sorkin.   

Abstract

Gabapentin (GBP) and S(+)-3-isobutyl-gamma-aminobutyric acid (IBG) are anticonvulsant agents which are effective against many clinical and experimental neuropathic pain states. We examined the efficacy of these agents in a new rat model of secondary mechanical hyperalgesia generated by a mild thermal injury. Under brief halothane anesthesia, an injury was induced by applying one heel to a hot surface (52.5 degreesC) for 45 s. GBP, IBG or saline was injected i.p. just prior to the injury. Mean mechanical withdrawal threshold (MWT) was determined using von Frey hairs before and at 30 min intervals for 3 h following the injury. MWT outside the injury area decreased post-injury (secondary hyperalgesia, allodynia), but primary (site of injury) mechanical hyperalgesia was not observed. Secondary hyperalgesia exhibited a tendency toward recovery over time. Time to onset of the anti-allodynic effect of GBP was 30-60 min. The minimum effective GBP dose was 100 mg/kg; 300 mg/kg GBP totally inhibited the drop in MWT, but was accompanied by pronounced sedation. Anti-allodynic effects of IBG were apparent at the first post-injury measure of MWT (30 min). Thirty milligrams per kilogram was the minimum effective dose; 100 mg/kg IBG totally blocked the allodynia with minimal side effects. Our findings demonstrate a dose-dependent blockade of the mechanical sensitivity caused by a mild thermal injury by both GBP and IBG. Results indicate that IBG is more effective than GBP in this model at doses which do not cause sedation. These observations support the suggested use of these or related gamma-amino acid analogues as an effective treatment for post-operative pain. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813259     DOI: 10.1016/s0006-8993(98)00890-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

Review 1.  Pregabalin: in the treatment of postherpetic neuralgia.

Authors:  James E Frampton; Rachel H Foster
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Misuse and abuse of pregabalin and gabapentin: cause for concern?

Authors:  Fabrizio Schifano
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

3.  Pregabalin abuse and dependence in Germany: results from a database query.

Authors:  Maximilian Gahr; Roland W Freudenmann; Christoph Hiemke; Makus A Kölle; Carlos Schönfeldt-Lecuona
Journal:  Eur J Clin Pharmacol       Date:  2013-01-05       Impact factor: 2.953

4.  Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans.

Authors:  G D Iannetti; L Zambreanu; R G Wise; T J Buchanan; J P Huggins; T S Smart; W Vennart; I Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

Review 5.  The pathophysiology of acute pain: animal models.

Authors:  Jun Xu; Timothy J Brennan
Journal:  Curr Opin Anaesthesiol       Date:  2011-10       Impact factor: 2.706

6.  Effects of distal nerve injuries on dorsal-horn neurons and glia: relationships between lesion size and mechanical hyperalgesia.

Authors:  J W Lee; S M Siegel; A L Oaklander
Journal:  Neuroscience       Date:  2008-10-11       Impact factor: 3.590

7.  Spinal p38 mitogen-activated protein kinase mediates allodynia induced by first-degree burn in the rat.

Authors:  Linda Sorkin; Camilla I Svensson; Toni L Jones-Cordero; Michael P Hefferan; W Marie Campana
Journal:  J Neurosci Res       Date:  2009-03       Impact factor: 4.164

8.  Oral pregabalin for postoperative pain relief after third molar extraction: a randomized controlled clinical trial.

Authors:  Maria Victoria Olmedo-Gaya; Francisco J Manzano-Moreno; Rafael Galvez-Mateos; Maria Paloma González-Rodriguez; Cristina Talero-Sevilla; Manuel Vallecillo-Capilla
Journal:  Clin Oral Investig       Date:  2015-11-18       Impact factor: 3.573

Review 9.  Pregabalin: in the treatment of postherpetic neuralgia.

Authors:  Kate McKeage; Susan J Keam
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

10.  Effects of pregabalin on visceral pain responses and colonic compliance in rats.

Authors:  A Ravnefjord; M Brusberg; H Larsson; E Lindström; V Martínez
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.